Keywords: Valeant, OraPharma, Oral health, M&A, Term loan

Valeant goes shopping again, this time for OraPharma

Article | 18 June 2012

Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) said Friday that it has agreed to acquire OraPharma, a USA-based specialty ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in